Format

Send to

Choose Destination
See comment in PubMed Commons below
BMJ. 2000 Jun 17;320(7250):1635-40.

US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey.

Author information

1
Veterans Administration Outcomes Group (111B), Veterans Administration Medical Center, White River Junction, VT 05009, USA. lisa.schwartz@dartmouth.edu

Abstract

OBJECTIVE:

To determine women's attitudes to and knowledge of both false positive mammography results and the detection of ductal carcinoma in situ after screening mammography.

DESIGN:

Cross sectional survey.

SETTING:

United States.

PARTICIPANTS:

479 women aged 18-97 years who did not report a history of breast cancer.

MAIN OUTCOME MEASURES:

Attitudes to and knowledge of false positive results and the detection of ductal carcinoma in situ after screening mammography.

RESULTS:

Women were aware that false positive results do occur. Their median estimate of the false positive rate for 10 years of annual screening was 20% (25th percentile estimate, 10%; 75th percentile estimate, 45%). The women were highly tolerant of false positives: 63% thought that 500 or more false positives per life saved was reasonable and 37% would tolerate 10 000 or more. Women who had had a false positive result (n=76) expressed the same high tolerance: 39% would tolerate 10 000 or more false positives. 62% of women did not want to take false positive results into account when deciding about screening. Only 8% of women thought that mammography could harm a woman without breast cancer, and 94% doubted the possibility of non-progressive breast cancers. Few had heard about ductal carcinoma in situ, a cancer that may not progress, but when informed, 60% of women wanted to take into account the possibility of it being detected when deciding about screening.

CONCLUSIONS:

Women are aware of false positives and seem to view them as an acceptable consequence of screening mammography. In contrast, most women are unaware that screening can detect cancers that may never progress but feel that such information would be relevant. Education should perhaps focus less on false positives and more on the less familiar outcome of detection of ductal carcinoma in situ.

PMID:
10856064
PMCID:
PMC27408
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center